STAT3 and neoplasm: This may be attributed to the increased tumor burden in advanced stages, or to the pathogenetic role of these molecules in disease progression, as, in two studies using cell lines, the activity of STAT5/BIC/miR-155 [13] and JAK/STAT3/STAT4/miR-146a [36] pathways was associated with disease progression.